In a report released yesterday, Akshay Jagdale from Jefferies maintained a Buy rating on Herbalife (HLF), with a price target of $65. The company’s shares opened today at $56.63.
Jagdale commented:
“We are updating our estimates following 4Q results & CAGNY presentation. Despite softer than expected 4Q results & uncertainty around China business, we maintain that FY19 guidance will likely end up being conservative owing to positive momentum in sales in most regions ex-China. We continue to believe that HLF can sustainably grow sales at least in line with its TAM growth rate (~6%), expand margins, & drive incremental earnings upside via accretive FCF usage.”
According to TipRanks.com, Jagdale is a 3-star analyst with an average return of 1.3% and a 49.6% success rate. Jagdale covers the Consumer Goods sector, focusing on stocks such as Lamb Weston Holdings, McCormick & Company, and Conagra Brands Inc.
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Herbalife with a $63.67 average price target, implying a 12.4% upside from current levels. In a report issued on February 20, Pivotal Research also maintained a Buy rating on the stock with a $70 price target.
See today’s analyst top recommended stocks >>
The company has a one-year high of $61.77 and a one-year low of $42.72. Currently, Herbalife has an average volume of 1.33M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Herbalife Nutrition Ltd. is a holding company, which engages in the development and sale of nutrition solutions. It operates through the following segments: North America; Mexico; South and Central America; Europe, Middle East, and Africa; Asia pacific; and China.
